X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AMGN

Closed

Amgen Inc

290.52
+11.31 (+4.05%)
Last Update: 01 Jul 2025 23:11:00
Yesterday: 279.21
Day's Range: 278.98 - 293.98
Send
When Written:
 
241.75
Amgen Inc. is a multinational biopharmaceutical company headquartered in Thousand Oaks, California, United States. It was founded in 1980 by William K. Bowes Jr. and George B. Rathmann. The company's primary focus is on the development and marketing of drugs for the treatment of serious illnesses like cancer, cardiovascular disease, and kidney disease.

Amgen is one of the largest biotechnology companies in the world, with a market capitalization of over $130 billion. The company has a global presence, with operations in over 100 countries and a workforce of over 23,000 employees.

Some of Amgen's most well-known products include Enbrel (for rheumatoid arthritis and psoriasis), Neulasta (for chemotherapy-induced neutropenia), and Prolia (for osteoporosis). The company is also actively involved in research and development, with a focus on biologic drugs and biosimilars.

Amgen has been recognized for its commitment to sustainability and corporate responsibility, with a number of awards and accolades. The company has also been recognized for its commitment to diversity and inclusion, with a focus on creating a diverse and inclusive workplace culture.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.15
X